nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—endogenous depression—Citalopram—alcohol dependence	0.328	1	CpDpCtD
Nefazodone—SLC6A3—alcohol dependence	0.114	0.431	CbGaD
Nefazodone—SLC6A4—alcohol dependence	0.0855	0.322	CbGaD
Nefazodone—HTR2A—alcohol dependence	0.0657	0.247	CbGaD
Nefazodone—SLC6A3—Citalopram—alcohol dependence	0.0435	0.178	CbGbCtD
Nefazodone—SLC6A4—Citalopram—alcohol dependence	0.038	0.156	CbGbCtD
Nefazodone—SLC6A2—Citalopram—alcohol dependence	0.0318	0.13	CbGbCtD
Nefazodone—HTR2C—Citalopram—alcohol dependence	0.0318	0.13	CbGbCtD
Nefazodone—ADRA1A—Citalopram—alcohol dependence	0.0275	0.113	CbGbCtD
Nefazodone—CYP3A5—Disulfiram—alcohol dependence	0.0218	0.0895	CbGbCtD
Nefazodone—ABCB1—Naltrexone—alcohol dependence	0.0153	0.0626	CbGbCtD
Nefazodone—ABCB1—Citalopram—alcohol dependence	0.0101	0.0415	CbGbCtD
Nefazodone—CYP2D6—Citalopram—alcohol dependence	0.00954	0.0391	CbGbCtD
Nefazodone—CYP3A4—Disulfiram—alcohol dependence	0.00851	0.0349	CbGbCtD
Nefazodone—CYP3A4—Citalopram—alcohol dependence	0.00607	0.0249	CbGbCtD
Nefazodone—SLC6A2—locus ceruleus—alcohol dependence	0.00202	0.0823	CbGeAlD
Nefazodone—HTR2A—locus ceruleus—alcohol dependence	0.00121	0.0494	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—alcohol dependence	0.00107	0.0437	CbGeAlD
Nefazodone—HTR2A—cerebellar cortex—alcohol dependence	0.00099	0.0403	CbGeAlD
Nefazodone—SLC6A3—nerve—alcohol dependence	0.000749	0.0305	CbGeAlD
Nefazodone—HTR2A—pons—alcohol dependence	0.0007	0.0285	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—alcohol dependence	0.000646	0.0263	CbGeAlD
Nefazodone—SLC6A2—nerve—alcohol dependence	0.000604	0.0246	CbGeAlD
Nefazodone—HTR2A—nerve—alcohol dependence	0.000363	0.0148	CbGeAlD
Nefazodone—SLC6A3—brainstem—alcohol dependence	0.000321	0.0131	CbGeAlD
Nefazodone—HTR2C—brainstem—alcohol dependence	0.000311	0.0126	CbGeAlD
Nefazodone—SLC6A3—forebrain—alcohol dependence	0.00031	0.0126	CbGeAlD
Nefazodone—CYP3A7—endocrine gland—alcohol dependence	0.000306	0.0124	CbGeAlD
Nefazodone—HTR2C—forebrain—alcohol dependence	0.0003	0.0122	CbGeAlD
Nefazodone—SLC6A4—brainstem—alcohol dependence	0.000295	0.012	CbGeAlD
Nefazodone—SLC6A4—forebrain—alcohol dependence	0.000284	0.0116	CbGeAlD
Nefazodone—CYP3A7—liver—alcohol dependence	0.000276	0.0112	CbGeAlD
Nefazodone—HTR1A—brainstem—alcohol dependence	0.000262	0.0106	CbGeAlD
Nefazodone—SLC6A2—brainstem—alcohol dependence	0.000259	0.0106	CbGeAlD
Nefazodone—HTR1A—forebrain—alcohol dependence	0.000252	0.0103	CbGeAlD
Nefazodone—SLC6A2—forebrain—alcohol dependence	0.00025	0.0102	CbGeAlD
Nefazodone—ADRA1A—brainstem—alcohol dependence	0.000241	0.00981	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000234	0.00954	CbGeAlD
Nefazodone—ADRA1A—forebrain—alcohol dependence	0.000233	0.00947	CbGeAlD
Nefazodone—ADRA1B—nervous system—alcohol dependence	0.000225	0.00915	CbGeAlD
Nefazodone—ADRA1B—central nervous system—alcohol dependence	0.000216	0.00881	CbGeAlD
Nefazodone—HTR1A—cardiovascular system—alcohol dependence	0.000213	0.00869	CbGeAlD
Nefazodone—SLC6A3—midbrain—alcohol dependence	0.000205	0.00834	CbGeAlD
Nefazodone—SLC6A4—digestive system—alcohol dependence	0.0002	0.00812	CbGeAlD
Nefazodone—HTR2C—midbrain—alcohol dependence	0.000198	0.00806	CbGeAlD
Nefazodone—ADRA1A—cardiovascular system—alcohol dependence	0.000197	0.00801	CbGeAlD
Nefazodone—SLC6A2—gonad—alcohol dependence	0.000192	0.00782	CbGeAlD
Nefazodone—SLC6A4—blood—alcohol dependence	0.00019	0.00774	CbGeAlD
Nefazodone—SLC6A4—midbrain—alcohol dependence	0.000188	0.00764	CbGeAlD
Nefazodone—ADRA2A—forebrain—alcohol dependence	0.000177	0.0072	CbGeAlD
Nefazodone—ADRA1B—brain—alcohol dependence	0.000172	0.00699	CbGeAlD
Nefazodone—SLC6A3—testis—alcohol dependence	0.000172	0.00698	CbGeAlD
Nefazodone—SLC6A3—nervous system—alcohol dependence	0.000168	0.00685	CbGeAlD
Nefazodone—HTR1A—midbrain—alcohol dependence	0.000167	0.00678	CbGeAlD
Nefazodone—SLC6A4—endocrine gland—alcohol dependence	0.000165	0.00671	CbGeAlD
Nefazodone—HTR2C—nervous system—alcohol dependence	0.000163	0.00663	CbGeAlD
Nefazodone—SLC6A3—central nervous system—alcohol dependence	0.000162	0.0066	CbGeAlD
Nefazodone—SLC6A3—cerebellum—alcohol dependence	0.000158	0.00645	CbGeAlD
Nefazodone—HTR2C—central nervous system—alcohol dependence	0.000157	0.00638	CbGeAlD
Nefazodone—HTR2A—brainstem—alcohol dependence	0.000156	0.00634	CbGeAlD
Nefazodone—ADRA1A—blood—alcohol dependence	0.000156	0.00633	CbGeAlD
Nefazodone—SLC6A4—nervous system—alcohol dependence	0.000154	0.00628	CbGeAlD
Nefazodone—CYP3A5—pancreas—alcohol dependence	0.000153	0.00621	CbGeAlD
Nefazodone—HTR2A—forebrain—alcohol dependence	0.00015	0.00612	CbGeAlD
Nefazodone—SLC6A4—central nervous system—alcohol dependence	0.000149	0.00605	CbGeAlD
Nefazodone—HTR1A—endocrine gland—alcohol dependence	0.000146	0.00596	CbGeAlD
Nefazodone—ADRA2A—pancreas—alcohol dependence	0.000145	0.00592	CbGeAlD
Nefazodone—SLC6A2—endocrine gland—alcohol dependence	0.000145	0.00591	CbGeAlD
Nefazodone—CYP2D6—brainstem—alcohol dependence	0.000142	0.00578	CbGeAlD
Nefazodone—Acetophenazine—DRD2—alcohol dependence	0.000139	0.0549	CrCbGaD
Nefazodone—SLC6A2—testis—alcohol dependence	0.000138	0.00563	CbGeAlD
Nefazodone—CYP2D6—forebrain—alcohol dependence	0.000137	0.00558	CbGeAlD
Nefazodone—HTR1A—nervous system—alcohol dependence	0.000137	0.00558	CbGeAlD
Nefazodone—Aripiprazole—DRD4—alcohol dependence	0.000137	0.0538	CrCbGaD
Nefazodone—SLC6A2—nervous system—alcohol dependence	0.000136	0.00553	CbGeAlD
Nefazodone—ADRA2A—gonad—alcohol dependence	0.000136	0.00553	CbGeAlD
Nefazodone—ADRA1A—endocrine gland—alcohol dependence	0.000135	0.00549	CbGeAlD
Nefazodone—HTR1A—central nervous system—alcohol dependence	0.000132	0.00537	CbGeAlD
Nefazodone—SLC6A2—central nervous system—alcohol dependence	0.000131	0.00532	CbGeAlD
Nefazodone—CYP3A5—digestive system—alcohol dependence	0.00013	0.0053	CbGeAlD
Nefazodone—HTR1A—cerebellum—alcohol dependence	0.000129	0.00525	CbGeAlD
Nefazodone—SLC6A3—brain—alcohol dependence	0.000129	0.00524	CbGeAlD
Nefazodone—HTR2A—cardiovascular system—alcohol dependence	0.000127	0.00518	CbGeAlD
Nefazodone—ADRA1A—nervous system—alcohol dependence	0.000126	0.00514	CbGeAlD
Nefazodone—Aripiprazole—CHRM2—alcohol dependence	0.000126	0.0496	CrCbGaD
Nefazodone—Aripiprazole—HTR7—alcohol dependence	0.000125	0.0494	CrCbGaD
Nefazodone—Deafness—Citalopram—alcohol dependence	0.000125	0.00139	CcSEcCtD
Nefazodone—Hepatic failure—Citalopram—alcohol dependence	0.000125	0.00139	CcSEcCtD
Nefazodone—Eczema—Citalopram—alcohol dependence	0.000125	0.00139	CcSEcCtD
Nefazodone—Visual impairment—Acamprosate—alcohol dependence	0.000125	0.00139	CcSEcCtD
Nefazodone—HTR2C—brain—alcohol dependence	0.000124	0.00506	CbGeAlD
Nefazodone—Eye pain—Citalopram—alcohol dependence	0.000124	0.00138	CcSEcCtD
Nefazodone—CYP3A5—blood—alcohol dependence	0.000124	0.00505	CbGeAlD
Nefazodone—Dizziness—Disulfiram—alcohol dependence	0.000123	0.00137	CcSEcCtD
Nefazodone—Hepatitis—Naltrexone—alcohol dependence	0.000122	0.00136	CcSEcCtD
Nefazodone—Injury—Citalopram—alcohol dependence	0.000122	0.00136	CcSEcCtD
Nefazodone—Hallucination—Naltrexone—alcohol dependence	0.000122	0.00135	CcSEcCtD
Nefazodone—ADRA1A—liver—alcohol dependence	0.000122	0.00495	CbGeAlD
Nefazodone—ADRA1A—central nervous system—alcohol dependence	0.000122	0.00495	CbGeAlD
Nefazodone—Pharyngitis—Naltrexone—alcohol dependence	0.000122	0.00135	CcSEcCtD
Nefazodone—Aripiprazole—HTR1B—alcohol dependence	0.000121	0.0478	CrCbGaD
Nefazodone—Libido decreased—Citalopram—alcohol dependence	0.000121	0.00134	CcSEcCtD
Nefazodone—Tinnitus—Acamprosate—alcohol dependence	0.000121	0.00134	CcSEcCtD
Nefazodone—Increased appetite—Citalopram—alcohol dependence	0.000119	0.00133	CcSEcCtD
Nefazodone—ADRA1A—cerebellum—alcohol dependence	0.000119	0.00484	CbGeAlD
Nefazodone—Visual disturbance—Citalopram—alcohol dependence	0.000118	0.00131	CcSEcCtD
Nefazodone—ADRA2A—blood—alcohol dependence	0.000118	0.00482	CbGeAlD
Nefazodone—SLC6A4—brain—alcohol dependence	0.000118	0.0048	CbGeAlD
Nefazodone—Thirst—Citalopram—alcohol dependence	0.000118	0.00131	CcSEcCtD
Nefazodone—Rash—Disulfiram—alcohol dependence	0.000118	0.00131	CcSEcCtD
Nefazodone—Dermatitis bullous—Citalopram—alcohol dependence	0.000117	0.0013	CcSEcCtD
Nefazodone—Headache—Disulfiram—alcohol dependence	0.000117	0.0013	CcSEcCtD
Nefazodone—ADRA2A—midbrain—alcohol dependence	0.000117	0.00476	CbGeAlD
Nefazodone—Chills—Acamprosate—alcohol dependence	0.000116	0.00129	CcSEcCtD
Nefazodone—HTR2A—gonad—alcohol dependence	0.000115	0.0047	CbGeAlD
Nefazodone—Arthritis—Citalopram—alcohol dependence	0.000115	0.00128	CcSEcCtD
Nefazodone—Hypoglycaemia—Citalopram—alcohol dependence	0.000115	0.00128	CcSEcCtD
Nefazodone—Cerebrovascular accident—Citalopram—alcohol dependence	0.000114	0.00127	CcSEcCtD
Nefazodone—Alopecia—Acamprosate—alcohol dependence	0.000114	0.00127	CcSEcCtD
Nefazodone—Tinnitus—Naltrexone—alcohol dependence	0.000114	0.00127	CcSEcCtD
Nefazodone—Hyponatraemia—Citalopram—alcohol dependence	0.000113	0.00125	CcSEcCtD
Nefazodone—Prochlorperazine—CHRM2—alcohol dependence	0.000112	0.0442	CrCbGaD
Nefazodone—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000112	0.00125	CcSEcCtD
Nefazodone—Diplopia—Citalopram—alcohol dependence	0.000112	0.00125	CcSEcCtD
Nefazodone—Osteoarthritis—Citalopram—alcohol dependence	0.000112	0.00125	CcSEcCtD
Nefazodone—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000111	0.00124	CcSEcCtD
Nefazodone—Flatulence—Acamprosate—alcohol dependence	0.000111	0.00123	CcSEcCtD
Nefazodone—Affect lability—Citalopram—alcohol dependence	0.00011	0.00123	CcSEcCtD
Nefazodone—Migraine—Citalopram—alcohol dependence	0.00011	0.00123	CcSEcCtD
Nefazodone—Dysgeusia—Acamprosate—alcohol dependence	0.00011	0.00123	CcSEcCtD
Nefazodone—Chills—Naltrexone—alcohol dependence	0.00011	0.00122	CcSEcCtD
Nefazodone—Back pain—Acamprosate—alcohol dependence	0.000109	0.00121	CcSEcCtD
Nefazodone—Muscle spasms—Acamprosate—alcohol dependence	0.000108	0.0012	CcSEcCtD
Nefazodone—Face oedema—Citalopram—alcohol dependence	0.000108	0.0012	CcSEcCtD
Nefazodone—Alopecia—Naltrexone—alcohol dependence	0.000108	0.0012	CcSEcCtD
Nefazodone—CYP3A5—endocrine gland—alcohol dependence	0.000108	0.00438	CbGeAlD
Nefazodone—Urinary retention—Citalopram—alcohol dependence	0.000107	0.00118	CcSEcCtD
Nefazodone—Mood swings—Citalopram—alcohol dependence	0.000106	0.00118	CcSEcCtD
Nefazodone—Domperidone—DRD2—alcohol dependence	0.000106	0.0416	CrCbGaD
Nefazodone—HTR2A—digestive system—alcohol dependence	0.000106	0.0043	CbGeAlD
Nefazodone—Tremor—Acamprosate—alcohol dependence	0.000106	0.00117	CcSEcCtD
Nefazodone—Ataxia—Citalopram—alcohol dependence	0.000105	0.00117	CcSEcCtD
Nefazodone—Flatulence—Naltrexone—alcohol dependence	0.000105	0.00117	CcSEcCtD
Nefazodone—HTR1A—brain—alcohol dependence	0.000105	0.00426	CbGeAlD
Nefazodone—Ill-defined disorder—Acamprosate—alcohol dependence	0.000105	0.00116	CcSEcCtD
Nefazodone—Dysgeusia—Naltrexone—alcohol dependence	0.000104	0.00116	CcSEcCtD
Nefazodone—Dehydration—Citalopram—alcohol dependence	0.000104	0.00116	CcSEcCtD
Nefazodone—Anaemia—Acamprosate—alcohol dependence	0.000104	0.00116	CcSEcCtD
Nefazodone—SLC6A2—brain—alcohol dependence	0.000104	0.00423	CbGeAlD
Nefazodone—Liver function test abnormal—Citalopram—alcohol dependence	0.000104	0.00115	CcSEcCtD
Nefazodone—Agitation—Acamprosate—alcohol dependence	0.000104	0.00115	CcSEcCtD
Nefazodone—Back pain—Naltrexone—alcohol dependence	0.000103	0.00115	CcSEcCtD
Nefazodone—Angioedema—Acamprosate—alcohol dependence	0.000103	0.00114	CcSEcCtD
Nefazodone—Dry skin—Citalopram—alcohol dependence	0.000103	0.00114	CcSEcCtD
Nefazodone—ADRA2A—endocrine gland—alcohol dependence	0.000103	0.00418	CbGeAlD
Nefazodone—Muscle spasms—Naltrexone—alcohol dependence	0.000102	0.00114	CcSEcCtD
Nefazodone—Orthostatic hypotension—Citalopram—alcohol dependence	0.000102	0.00114	CcSEcCtD
Nefazodone—Malaise—Acamprosate—alcohol dependence	0.000102	0.00113	CcSEcCtD
Nefazodone—Vertigo—Acamprosate—alcohol dependence	0.000101	0.00112	CcSEcCtD
Nefazodone—Syncope—Acamprosate—alcohol dependence	0.000101	0.00112	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000101	0.00112	CcSEcCtD
Nefazodone—Cramp muscle—Citalopram—alcohol dependence	0.000101	0.00112	CcSEcCtD
Nefazodone—Leukopenia—Acamprosate—alcohol dependence	0.000101	0.00112	CcSEcCtD
Nefazodone—HTR2A—blood—alcohol dependence	0.000101	0.00409	CbGeAlD
Nefazodone—Vision blurred—Naltrexone—alcohol dependence	0.0001	0.00112	CcSEcCtD
Nefazodone—Tremor—Naltrexone—alcohol dependence	9.99e-05	0.00111	CcSEcCtD
Nefazodone—Palpitations—Acamprosate—alcohol dependence	9.95e-05	0.00111	CcSEcCtD
Nefazodone—HTR2A—midbrain—alcohol dependence	9.93e-05	0.00404	CbGeAlD
Nefazodone—Gastritis—Citalopram—alcohol dependence	9.92e-05	0.0011	CcSEcCtD
Nefazodone—Loss of consciousness—Acamprosate—alcohol dependence	9.9e-05	0.0011	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Citalopram—alcohol dependence	9.89e-05	0.0011	CcSEcCtD
Nefazodone—Ill-defined disorder—Naltrexone—alcohol dependence	9.89e-05	0.0011	CcSEcCtD
Nefazodone—ABCB1—forebrain—alcohol dependence	9.86e-05	0.00401	CbGeAlD
Nefazodone—Cough—Acamprosate—alcohol dependence	9.83e-05	0.00109	CcSEcCtD
Nefazodone—Agitation—Naltrexone—alcohol dependence	9.79e-05	0.00109	CcSEcCtD
Nefazodone—ADRA2A—testis—alcohol dependence	9.79e-05	0.00398	CbGeAlD
Nefazodone—CYP3A4—digestive system—alcohol dependence	9.78e-05	0.00398	CbGeAlD
Nefazodone—Convulsion—Acamprosate—alcohol dependence	9.76e-05	0.00108	CcSEcCtD
Nefazodone—Abdominal distension—Citalopram—alcohol dependence	9.76e-05	0.00108	CcSEcCtD
Nefazodone—Angioedema—Naltrexone—alcohol dependence	9.74e-05	0.00108	CcSEcCtD
Nefazodone—Hypertension—Acamprosate—alcohol dependence	9.73e-05	0.00108	CcSEcCtD
Nefazodone—CYP3A5—liver—alcohol dependence	9.71e-05	0.00395	CbGeAlD
Nefazodone—Dysphagia—Citalopram—alcohol dependence	9.69e-05	0.00108	CcSEcCtD
Nefazodone—Influenza—Citalopram—alcohol dependence	9.69e-05	0.00108	CcSEcCtD
Nefazodone—Asthma—Citalopram—alcohol dependence	9.69e-05	0.00108	CcSEcCtD
Nefazodone—ADRA1A—brain—alcohol dependence	9.66e-05	0.00393	CbGeAlD
Nefazodone—CYP2D6—digestive system—alcohol dependence	9.62e-05	0.00392	CbGeAlD
Nefazodone—Malaise—Naltrexone—alcohol dependence	9.61e-05	0.00107	CcSEcCtD
Nefazodone—ADRA2A—nervous system—alcohol dependence	9.61e-05	0.00391	CbGeAlD
Nefazodone—Myalgia—Acamprosate—alcohol dependence	9.59e-05	0.00107	CcSEcCtD
Nefazodone—Arthralgia—Acamprosate—alcohol dependence	9.59e-05	0.00107	CcSEcCtD
Nefazodone—Chest pain—Acamprosate—alcohol dependence	9.59e-05	0.00107	CcSEcCtD
Nefazodone—Syncope—Naltrexone—alcohol dependence	9.56e-05	0.00106	CcSEcCtD
Nefazodone—Anxiety—Acamprosate—alcohol dependence	9.56e-05	0.00106	CcSEcCtD
Nefazodone—Discomfort—Acamprosate—alcohol dependence	9.48e-05	0.00105	CcSEcCtD
Nefazodone—Angina pectoris—Citalopram—alcohol dependence	9.44e-05	0.00105	CcSEcCtD
Nefazodone—Palpitations—Naltrexone—alcohol dependence	9.42e-05	0.00105	CcSEcCtD
Nefazodone—Dry mouth—Acamprosate—alcohol dependence	9.38e-05	0.00104	CcSEcCtD
Nefazodone—Loss of consciousness—Naltrexone—alcohol dependence	9.37e-05	0.00104	CcSEcCtD
Nefazodone—Bronchitis—Citalopram—alcohol dependence	9.32e-05	0.00104	CcSEcCtD
Nefazodone—CYP3A4—blood—alcohol dependence	9.31e-05	0.00379	CbGeAlD
Nefazodone—Cough—Naltrexone—alcohol dependence	9.3e-05	0.00103	CcSEcCtD
Nefazodone—Confusional state—Acamprosate—alcohol dependence	9.27e-05	0.00103	CcSEcCtD
Nefazodone—ADRA2A—central nervous system—alcohol dependence	9.25e-05	0.00376	CbGeAlD
Nefazodone—Convulsion—Naltrexone—alcohol dependence	9.23e-05	0.00103	CcSEcCtD
Nefazodone—Hypertension—Naltrexone—alcohol dependence	9.2e-05	0.00102	CcSEcCtD
Nefazodone—Anaphylactic shock—Acamprosate—alcohol dependence	9.19e-05	0.00102	CcSEcCtD
Nefazodone—CYP2D6—blood—alcohol dependence	9.17e-05	0.00373	CbGeAlD
Nefazodone—ABCB1—adrenal cortex—alcohol dependence	9.14e-05	0.00372	CbGeAlD
Nefazodone—Infection—Acamprosate—alcohol dependence	9.13e-05	0.00101	CcSEcCtD
Nefazodone—Chest pain—Naltrexone—alcohol dependence	9.07e-05	0.00101	CcSEcCtD
Nefazodone—Arthralgia—Naltrexone—alcohol dependence	9.07e-05	0.00101	CcSEcCtD
Nefazodone—Myalgia—Naltrexone—alcohol dependence	9.07e-05	0.00101	CcSEcCtD
Nefazodone—Dysuria—Citalopram—alcohol dependence	9.06e-05	0.00101	CcSEcCtD
Nefazodone—Shock—Acamprosate—alcohol dependence	9.04e-05	0.001	CcSEcCtD
Nefazodone—Anxiety—Naltrexone—alcohol dependence	9.04e-05	0.001	CcSEcCtD
Nefazodone—ADRA2A—cerebellum—alcohol dependence	9.04e-05	0.00368	CbGeAlD
Nefazodone—Thrombocytopenia—Acamprosate—alcohol dependence	9e-05	0.001	CcSEcCtD
Nefazodone—Tachycardia—Acamprosate—alcohol dependence	8.97e-05	0.000997	CcSEcCtD
Nefazodone—Discomfort—Naltrexone—alcohol dependence	8.96e-05	0.000996	CcSEcCtD
Nefazodone—Pollakiuria—Citalopram—alcohol dependence	8.95e-05	0.000994	CcSEcCtD
Nefazodone—Erectile dysfunction—Citalopram—alcohol dependence	8.93e-05	0.000991	CcSEcCtD
Nefazodone—Hyperhidrosis—Acamprosate—alcohol dependence	8.89e-05	0.000987	CcSEcCtD
Nefazodone—Dry mouth—Naltrexone—alcohol dependence	8.87e-05	0.000986	CcSEcCtD
Nefazodone—Photosensitivity reaction—Citalopram—alcohol dependence	8.85e-05	0.000983	CcSEcCtD
Nefazodone—Zuclopenthixol—DRD2—alcohol dependence	8.83e-05	0.0347	CrCbGaD
Nefazodone—Weight increased—Citalopram—alcohol dependence	8.82e-05	0.00098	CcSEcCtD
Nefazodone—Confusional state—Naltrexone—alcohol dependence	8.77e-05	0.000974	CcSEcCtD
Nefazodone—Weight decreased—Citalopram—alcohol dependence	8.77e-05	0.000974	CcSEcCtD
Nefazodone—Anorexia—Acamprosate—alcohol dependence	8.76e-05	0.000973	CcSEcCtD
Nefazodone—HTR2A—endocrine gland—alcohol dependence	8.73e-05	0.00355	CbGeAlD
Nefazodone—Anaphylactic shock—Naltrexone—alcohol dependence	8.7e-05	0.000966	CcSEcCtD
Nefazodone—Oedema—Naltrexone—alcohol dependence	8.7e-05	0.000966	CcSEcCtD
Nefazodone—Pneumonia—Citalopram—alcohol dependence	8.69e-05	0.000965	CcSEcCtD
Nefazodone—Infection—Naltrexone—alcohol dependence	8.64e-05	0.00096	CcSEcCtD
Nefazodone—Hypotension—Acamprosate—alcohol dependence	8.59e-05	0.000954	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Citalopram—alcohol dependence	8.57e-05	0.000952	CcSEcCtD
Nefazodone—Shock—Naltrexone—alcohol dependence	8.56e-05	0.000951	CcSEcCtD
Nefazodone—Quetiapine—DRD4—alcohol dependence	8.54e-05	0.0336	CrCbGaD
Nefazodone—Tachycardia—Naltrexone—alcohol dependence	8.49e-05	0.000943	CcSEcCtD
Nefazodone—Stomatitis—Citalopram—alcohol dependence	8.42e-05	0.000936	CcSEcCtD
Nefazodone—Hyperhidrosis—Naltrexone—alcohol dependence	8.41e-05	0.000934	CcSEcCtD
Nefazodone—Urinary tract infection—Citalopram—alcohol dependence	8.4e-05	0.000933	CcSEcCtD
Nefazodone—Conjunctivitis—Citalopram—alcohol dependence	8.4e-05	0.000933	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Acamprosate—alcohol dependence	8.38e-05	0.00093	CcSEcCtD
Nefazodone—ABCB1—cardiovascular system—alcohol dependence	8.34e-05	0.00339	CbGeAlD
Nefazodone—HTR2A—testis—alcohol dependence	8.32e-05	0.00339	CbGeAlD
Nefazodone—Insomnia—Acamprosate—alcohol dependence	8.32e-05	0.000924	CcSEcCtD
Nefazodone—Anorexia—Naltrexone—alcohol dependence	8.29e-05	0.000921	CcSEcCtD
Nefazodone—Sweating—Citalopram—alcohol dependence	8.28e-05	0.00092	CcSEcCtD
Nefazodone—Paraesthesia—Acamprosate—alcohol dependence	8.26e-05	0.000917	CcSEcCtD
Nefazodone—Haematuria—Citalopram—alcohol dependence	8.24e-05	0.000915	CcSEcCtD
Nefazodone—Aripiprazole—SLC6A4—alcohol dependence	8.2e-05	0.0323	CrCbGaD
Nefazodone—Dyspnoea—Acamprosate—alcohol dependence	8.2e-05	0.00091	CcSEcCtD
Nefazodone—Somnolence—Acamprosate—alcohol dependence	8.17e-05	0.000908	CcSEcCtD
Nefazodone—HTR2A—nervous system—alcohol dependence	8.17e-05	0.00332	CbGeAlD
Nefazodone—Trazodone—SLC6A4—alcohol dependence	8.16e-05	0.0321	CrCbGaD
Nefazodone—Aripiprazole—DRD2—alcohol dependence	8.16e-05	0.0321	CrCbGaD
Nefazodone—Epistaxis—Citalopram—alcohol dependence	8.15e-05	0.000905	CcSEcCtD
Nefazodone—Trifluoperazine—CHRM2—alcohol dependence	8.12e-05	0.032	CrCbGaD
Nefazodone—Sinusitis—Citalopram—alcohol dependence	8.11e-05	0.0009	CcSEcCtD
Nefazodone—ABCB1—pancreas—alcohol dependence	8.1e-05	0.0033	CbGeAlD
Nefazodone—Dyspepsia—Acamprosate—alcohol dependence	8.09e-05	0.000899	CcSEcCtD
Nefazodone—CYP3A4—endocrine gland—alcohol dependence	8.08e-05	0.00329	CbGeAlD
Nefazodone—Decreased appetite—Acamprosate—alcohol dependence	7.99e-05	0.000888	CcSEcCtD
Nefazodone—Perphenazine—HTR7—alcohol dependence	7.99e-05	0.0315	CrCbGaD
Nefazodone—CYP2D6—endocrine gland—alcohol dependence	7.95e-05	0.00324	CbGeAlD
Nefazodone—Musculoskeletal discomfort—Naltrexone—alcohol dependence	7.92e-05	0.00088	CcSEcCtD
Nefazodone—Bradycardia—Citalopram—alcohol dependence	7.9e-05	0.000877	CcSEcCtD
Nefazodone—Quetiapine—CHRM2—alcohol dependence	7.87e-05	0.031	CrCbGaD
Nefazodone—HTR2A—liver—alcohol dependence	7.87e-05	0.0032	CbGeAlD
Nefazodone—Insomnia—Naltrexone—alcohol dependence	7.87e-05	0.000874	CcSEcCtD
Nefazodone—HTR2A—central nervous system—alcohol dependence	7.86e-05	0.0032	CbGeAlD
Nefazodone—Pain—Acamprosate—alcohol dependence	7.86e-05	0.000873	CcSEcCtD
Nefazodone—Constipation—Acamprosate—alcohol dependence	7.86e-05	0.000873	CcSEcCtD
Nefazodone—Quetiapine—HTR7—alcohol dependence	7.84e-05	0.0309	CrCbGaD
Nefazodone—Paraesthesia—Naltrexone—alcohol dependence	7.81e-05	0.000868	CcSEcCtD
Nefazodone—Haemoglobin—Citalopram—alcohol dependence	7.8e-05	0.000866	CcSEcCtD
Nefazodone—Rhinitis—Citalopram—alcohol dependence	7.78e-05	0.000864	CcSEcCtD
Nefazodone—Hepatitis—Citalopram—alcohol dependence	7.76e-05	0.000862	CcSEcCtD
Nefazodone—Haemorrhage—Citalopram—alcohol dependence	7.76e-05	0.000862	CcSEcCtD
Nefazodone—Dyspnoea—Naltrexone—alcohol dependence	7.75e-05	0.000861	CcSEcCtD
Nefazodone—Thioproperazine—DRD2—alcohol dependence	7.73e-05	0.0304	CrCbGaD
Nefazodone—Somnolence—Naltrexone—alcohol dependence	7.73e-05	0.000859	CcSEcCtD
Nefazodone—Hypoaesthesia—Citalopram—alcohol dependence	7.72e-05	0.000857	CcSEcCtD
Nefazodone—Hallucination—Citalopram—alcohol dependence	7.72e-05	0.000857	CcSEcCtD
Nefazodone—Pharyngitis—Citalopram—alcohol dependence	7.7e-05	0.000855	CcSEcCtD
Nefazodone—HTR2A—cerebellum—alcohol dependence	7.69e-05	0.00313	CbGeAlD
Nefazodone—Oedema peripheral—Citalopram—alcohol dependence	7.64e-05	0.000849	CcSEcCtD
Nefazodone—Quetiapine—HTR1B—alcohol dependence	7.59e-05	0.0299	CrCbGaD
Nefazodone—CYP2D6—testis—alcohol dependence	7.58e-05	0.00309	CbGeAlD
Nefazodone—Feeling abnormal—Acamprosate—alcohol dependence	7.58e-05	0.000841	CcSEcCtD
Nefazodone—ABCB1—gonad—alcohol dependence	7.57e-05	0.00308	CbGeAlD
Nefazodone—Decreased appetite—Naltrexone—alcohol dependence	7.56e-05	0.00084	CcSEcCtD
Nefazodone—CYP3A4—nervous system—alcohol dependence	7.56e-05	0.00308	CbGeAlD
Nefazodone—Gastrointestinal pain—Acamprosate—alcohol dependence	7.52e-05	0.000835	CcSEcCtD
Nefazodone—Visual impairment—Citalopram—alcohol dependence	7.48e-05	0.00083	CcSEcCtD
Nefazodone—CYP2D6—nervous system—alcohol dependence	7.44e-05	0.00303	CbGeAlD
Nefazodone—Pain—Naltrexone—alcohol dependence	7.44e-05	0.000826	CcSEcCtD
Nefazodone—Constipation—Naltrexone—alcohol dependence	7.44e-05	0.000826	CcSEcCtD
Nefazodone—ADRA2A—brain—alcohol dependence	7.34e-05	0.00299	CbGeAlD
Nefazodone—Erythema multiforme—Citalopram—alcohol dependence	7.33e-05	0.000815	CcSEcCtD
Nefazodone—Urticaria—Acamprosate—alcohol dependence	7.3e-05	0.000811	CcSEcCtD
Nefazodone—CYP3A4—liver—alcohol dependence	7.28e-05	0.00296	CbGeAlD
Nefazodone—CYP3A4—central nervous system—alcohol dependence	7.28e-05	0.00296	CbGeAlD
Nefazodone—Prochlorperazine—DRD2—alcohol dependence	7.27e-05	0.0286	CrCbGaD
Nefazodone—Abdominal pain—Acamprosate—alcohol dependence	7.27e-05	0.000807	CcSEcCtD
Nefazodone—Body temperature increased—Acamprosate—alcohol dependence	7.27e-05	0.000807	CcSEcCtD
Nefazodone—Tinnitus—Citalopram—alcohol dependence	7.23e-05	0.000803	CcSEcCtD
Nefazodone—Flushing—Citalopram—alcohol dependence	7.2e-05	0.0008	CcSEcCtD
Nefazodone—Feeling abnormal—Naltrexone—alcohol dependence	7.17e-05	0.000796	CcSEcCtD
Nefazodone—CYP2D6—liver—alcohol dependence	7.17e-05	0.00292	CbGeAlD
Nefazodone—CYP2D6—central nervous system—alcohol dependence	7.16e-05	0.00292	CbGeAlD
Nefazodone—Gastrointestinal pain—Naltrexone—alcohol dependence	7.11e-05	0.00079	CcSEcCtD
Nefazodone—CYP2D6—cerebellum—alcohol dependence	7e-05	0.00285	CbGeAlD
Nefazodone—Chills—Citalopram—alcohol dependence	6.96e-05	0.000773	CcSEcCtD
Nefazodone—ABCB1—digestive system—alcohol dependence	6.92e-05	0.00282	CbGeAlD
Nefazodone—Urticaria—Naltrexone—alcohol dependence	6.91e-05	0.000768	CcSEcCtD
Nefazodone—Body temperature increased—Naltrexone—alcohol dependence	6.88e-05	0.000764	CcSEcCtD
Nefazodone—Abdominal pain—Naltrexone—alcohol dependence	6.88e-05	0.000764	CcSEcCtD
Nefazodone—Alopecia—Citalopram—alcohol dependence	6.85e-05	0.000761	CcSEcCtD
Nefazodone—Zuclopenthixol—HTR2A—alcohol dependence	6.82e-05	0.0269	CrCbGaD
Nefazodone—Hypersensitivity—Acamprosate—alcohol dependence	6.77e-05	0.000752	CcSEcCtD
Nefazodone—Flatulence—Citalopram—alcohol dependence	6.65e-05	0.000739	CcSEcCtD
Nefazodone—Dysgeusia—Citalopram—alcohol dependence	6.61e-05	0.000735	CcSEcCtD
Nefazodone—Asthenia—Acamprosate—alcohol dependence	6.6e-05	0.000733	CcSEcCtD
Nefazodone—ABCB1—blood—alcohol dependence	6.59e-05	0.00268	CbGeAlD
Nefazodone—Fluphenazine—DRD2—alcohol dependence	6.58e-05	0.0259	CrCbGaD
Nefazodone—Back pain—Citalopram—alcohol dependence	6.53e-05	0.000726	CcSEcCtD
Nefazodone—ABCB1—midbrain—alcohol dependence	6.51e-05	0.00265	CbGeAlD
Nefazodone—Pruritus—Acamprosate—alcohol dependence	6.5e-05	0.000722	CcSEcCtD
Nefazodone—Muscle spasms—Citalopram—alcohol dependence	6.49e-05	0.000721	CcSEcCtD
Nefazodone—Hypersensitivity—Naltrexone—alcohol dependence	6.41e-05	0.000712	CcSEcCtD
Nefazodone—Vision blurred—Citalopram—alcohol dependence	6.36e-05	0.000707	CcSEcCtD
Nefazodone—Fluphenazine—CYP2E1—alcohol dependence	6.33e-05	0.0249	CrCbGaD
Nefazodone—Tremor—Citalopram—alcohol dependence	6.33e-05	0.000703	CcSEcCtD
Nefazodone—Aripiprazole—HTR2A—alcohol dependence	6.3e-05	0.0248	CrCbGaD
Nefazodone—Diarrhoea—Acamprosate—alcohol dependence	6.29e-05	0.000699	CcSEcCtD
Nefazodone—Trazodone—HTR2A—alcohol dependence	6.27e-05	0.0247	CrCbGaD
Nefazodone—Ill-defined disorder—Citalopram—alcohol dependence	6.27e-05	0.000696	CcSEcCtD
Nefazodone—HTR2A—brain—alcohol dependence	6.24e-05	0.00254	CbGeAlD
Nefazodone—Anaemia—Citalopram—alcohol dependence	6.24e-05	0.000693	CcSEcCtD
Nefazodone—Asthenia—Naltrexone—alcohol dependence	6.24e-05	0.000693	CcSEcCtD
Nefazodone—Agitation—Citalopram—alcohol dependence	6.21e-05	0.000689	CcSEcCtD
Nefazodone—Angioedema—Citalopram—alcohol dependence	6.17e-05	0.000685	CcSEcCtD
Nefazodone—Pruritus—Naltrexone—alcohol dependence	6.15e-05	0.000684	CcSEcCtD
Nefazodone—Malaise—Citalopram—alcohol dependence	6.09e-05	0.000676	CcSEcCtD
Nefazodone—Dizziness—Acamprosate—alcohol dependence	6.08e-05	0.000675	CcSEcCtD
Nefazodone—Vertigo—Citalopram—alcohol dependence	6.07e-05	0.000674	CcSEcCtD
Nefazodone—Syncope—Citalopram—alcohol dependence	6.06e-05	0.000673	CcSEcCtD
Nefazodone—Leukopenia—Citalopram—alcohol dependence	6.04e-05	0.000671	CcSEcCtD
Nefazodone—Thioproperazine—HTR2A—alcohol dependence	5.98e-05	0.0235	CrCbGaD
Nefazodone—Palpitations—Citalopram—alcohol dependence	5.97e-05	0.000663	CcSEcCtD
Nefazodone—Diarrhoea—Naltrexone—alcohol dependence	5.95e-05	0.000661	CcSEcCtD
Nefazodone—Loss of consciousness—Citalopram—alcohol dependence	5.94e-05	0.000659	CcSEcCtD
Nefazodone—Cough—Citalopram—alcohol dependence	5.89e-05	0.000655	CcSEcCtD
Nefazodone—Convulsion—Citalopram—alcohol dependence	5.85e-05	0.00065	CcSEcCtD
Nefazodone—Vomiting—Acamprosate—alcohol dependence	5.85e-05	0.000649	CcSEcCtD
Nefazodone—Hypertension—Citalopram—alcohol dependence	5.83e-05	0.000648	CcSEcCtD
Nefazodone—Rash—Acamprosate—alcohol dependence	5.8e-05	0.000644	CcSEcCtD
Nefazodone—Dermatitis—Acamprosate—alcohol dependence	5.79e-05	0.000643	CcSEcCtD
Nefazodone—Headache—Acamprosate—alcohol dependence	5.76e-05	0.00064	CcSEcCtD
Nefazodone—Dizziness—Naltrexone—alcohol dependence	5.75e-05	0.000639	CcSEcCtD
Nefazodone—Chest pain—Citalopram—alcohol dependence	5.75e-05	0.000639	CcSEcCtD
Nefazodone—Myalgia—Citalopram—alcohol dependence	5.75e-05	0.000639	CcSEcCtD
Nefazodone—Arthralgia—Citalopram—alcohol dependence	5.75e-05	0.000639	CcSEcCtD
Nefazodone—Anxiety—Citalopram—alcohol dependence	5.73e-05	0.000636	CcSEcCtD
Nefazodone—ABCB1—endocrine gland—alcohol dependence	5.72e-05	0.00233	CbGeAlD
Nefazodone—CYP2D6—brain—alcohol dependence	5.69e-05	0.00231	CbGeAlD
Nefazodone—Discomfort—Citalopram—alcohol dependence	5.68e-05	0.000631	CcSEcCtD
Nefazodone—Dry mouth—Citalopram—alcohol dependence	5.62e-05	0.000625	CcSEcCtD
Nefazodone—Confusional state—Citalopram—alcohol dependence	5.56e-05	0.000617	CcSEcCtD
Nefazodone—Vomiting—Naltrexone—alcohol dependence	5.53e-05	0.000614	CcSEcCtD
Nefazodone—Oedema—Citalopram—alcohol dependence	5.51e-05	0.000612	CcSEcCtD
Nefazodone—Anaphylactic shock—Citalopram—alcohol dependence	5.51e-05	0.000612	CcSEcCtD
Nefazodone—Rash—Naltrexone—alcohol dependence	5.48e-05	0.000609	CcSEcCtD
Nefazodone—Dermatitis—Naltrexone—alcohol dependence	5.48e-05	0.000609	CcSEcCtD
Nefazodone—Infection—Citalopram—alcohol dependence	5.48e-05	0.000608	CcSEcCtD
Nefazodone—Nausea—Acamprosate—alcohol dependence	5.46e-05	0.000607	CcSEcCtD
Nefazodone—ABCB1—testis—alcohol dependence	5.45e-05	0.00222	CbGeAlD
Nefazodone—Headache—Naltrexone—alcohol dependence	5.45e-05	0.000605	CcSEcCtD
Nefazodone—Shock—Citalopram—alcohol dependence	5.42e-05	0.000602	CcSEcCtD
Nefazodone—Thrombocytopenia—Citalopram—alcohol dependence	5.4e-05	0.000599	CcSEcCtD
Nefazodone—Tachycardia—Citalopram—alcohol dependence	5.38e-05	0.000597	CcSEcCtD
Nefazodone—ABCB1—nervous system—alcohol dependence	5.35e-05	0.00218	CbGeAlD
Nefazodone—Hyperhidrosis—Citalopram—alcohol dependence	5.33e-05	0.000592	CcSEcCtD
Nefazodone—Trifluoperazine—DRD2—alcohol dependence	5.26e-05	0.0207	CrCbGaD
Nefazodone—Anorexia—Citalopram—alcohol dependence	5.25e-05	0.000584	CcSEcCtD
Nefazodone—Perphenazine—DRD2—alcohol dependence	5.2e-05	0.0205	CrCbGaD
Nefazodone—Nausea—Naltrexone—alcohol dependence	5.17e-05	0.000574	CcSEcCtD
Nefazodone—ABCB1—liver—alcohol dependence	5.16e-05	0.0021	CbGeAlD
Nefazodone—ABCB1—central nervous system—alcohol dependence	5.15e-05	0.0021	CbGeAlD
Nefazodone—Hypotension—Citalopram—alcohol dependence	5.15e-05	0.000572	CcSEcCtD
Nefazodone—Quetiapine—DRD2—alcohol dependence	5.1e-05	0.0201	CrCbGaD
Nefazodone—Fluphenazine—HTR2A—alcohol dependence	5.08e-05	0.02	CrCbGaD
Nefazodone—ABCB1—cerebellum—alcohol dependence	5.04e-05	0.00205	CbGeAlD
Nefazodone—Musculoskeletal discomfort—Citalopram—alcohol dependence	5.02e-05	0.000558	CcSEcCtD
Nefazodone—Insomnia—Citalopram—alcohol dependence	4.98e-05	0.000554	CcSEcCtD
Nefazodone—Paraesthesia—Citalopram—alcohol dependence	4.95e-05	0.00055	CcSEcCtD
Nefazodone—Dyspnoea—Citalopram—alcohol dependence	4.91e-05	0.000546	CcSEcCtD
Nefazodone—Somnolence—Citalopram—alcohol dependence	4.9e-05	0.000544	CcSEcCtD
Nefazodone—Dyspepsia—Citalopram—alcohol dependence	4.85e-05	0.000539	CcSEcCtD
Nefazodone—Decreased appetite—Citalopram—alcohol dependence	4.79e-05	0.000532	CcSEcCtD
Nefazodone—Constipation—Citalopram—alcohol dependence	4.71e-05	0.000523	CcSEcCtD
Nefazodone—Pain—Citalopram—alcohol dependence	4.71e-05	0.000523	CcSEcCtD
Nefazodone—Feeling abnormal—Citalopram—alcohol dependence	4.54e-05	0.000504	CcSEcCtD
Nefazodone—Gastrointestinal pain—Citalopram—alcohol dependence	4.51e-05	0.000501	CcSEcCtD
Nefazodone—Urticaria—Citalopram—alcohol dependence	4.38e-05	0.000486	CcSEcCtD
Nefazodone—Body temperature increased—Citalopram—alcohol dependence	4.36e-05	0.000484	CcSEcCtD
Nefazodone—Abdominal pain—Citalopram—alcohol dependence	4.36e-05	0.000484	CcSEcCtD
Nefazodone—ABCB1—brain—alcohol dependence	4.09e-05	0.00166	CbGeAlD
Nefazodone—Trifluoperazine—HTR2A—alcohol dependence	4.06e-05	0.016	CrCbGaD
Nefazodone—Hypersensitivity—Citalopram—alcohol dependence	4.06e-05	0.000451	CcSEcCtD
Nefazodone—Perphenazine—HTR2A—alcohol dependence	4.02e-05	0.0158	CrCbGaD
Nefazodone—Asthenia—Citalopram—alcohol dependence	3.95e-05	0.000439	CcSEcCtD
Nefazodone—Quetiapine—HTR2A—alcohol dependence	3.94e-05	0.0155	CrCbGaD
Nefazodone—Pruritus—Citalopram—alcohol dependence	3.9e-05	0.000433	CcSEcCtD
Nefazodone—Diarrhoea—Citalopram—alcohol dependence	3.77e-05	0.000419	CcSEcCtD
Nefazodone—Dizziness—Citalopram—alcohol dependence	3.64e-05	0.000405	CcSEcCtD
Nefazodone—Vomiting—Citalopram—alcohol dependence	3.5e-05	0.000389	CcSEcCtD
Nefazodone—Rash—Citalopram—alcohol dependence	3.47e-05	0.000386	CcSEcCtD
Nefazodone—Dermatitis—Citalopram—alcohol dependence	3.47e-05	0.000386	CcSEcCtD
Nefazodone—Headache—Citalopram—alcohol dependence	3.45e-05	0.000383	CcSEcCtD
Nefazodone—Nausea—Citalopram—alcohol dependence	3.27e-05	0.000364	CcSEcCtD
Nefazodone—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	9.82e-06	0.000216	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	9.81e-06	0.000216	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PDYN—alcohol dependence	9.79e-06	0.000215	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PDYN—alcohol dependence	9.74e-06	0.000214	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—OPRD1—alcohol dependence	9.73e-06	0.000214	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NPY—alcohol dependence	9.62e-06	0.000212	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—DRD2—alcohol dependence	9.62e-06	0.000212	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR7—alcohol dependence	9.62e-06	0.000212	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—DRD4—alcohol dependence	9.62e-06	0.000212	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	9.57e-06	0.00021	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	9.57e-06	0.00021	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CNR1—alcohol dependence	9.39e-06	0.000206	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	9.38e-06	0.000206	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PDYN—alcohol dependence	9.33e-06	0.000205	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR1B—alcohol dependence	9.28e-06	0.000204	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CRH—alcohol dependence	9.28e-06	0.000204	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CNR1—alcohol dependence	9.18e-06	0.000202	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADH4—alcohol dependence	9.18e-06	0.000202	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—DRD2—alcohol dependence	9.16e-06	0.000201	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR7—alcohol dependence	9.16e-06	0.000201	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	9.15e-06	0.000201	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	9.15e-06	0.000201	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CRHR1—alcohol dependence	9.1e-06	0.0002	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—WASF2—alcohol dependence	9.1e-06	0.0002	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ADH1B—alcohol dependence	9.07e-06	0.0002	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—WASF2—alcohol dependence	9.06e-06	0.000199	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	9.06e-06	0.000199	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—POMC—alcohol dependence	9.06e-06	0.000199	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR7—alcohol dependence	8.96e-06	0.000197	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—DRD2—alcohol dependence	8.96e-06	0.000197	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—DRD4—alcohol dependence	8.94e-06	0.000197	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	8.92e-06	0.000196	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—AVP—alcohol dependence	8.91e-06	0.000196	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	8.87e-06	0.000195	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—POMC—alcohol dependence	8.87e-06	0.000195	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALDH2—alcohol dependence	8.84e-06	0.000194	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	8.82e-06	0.000194	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—DRD4—alcohol dependence	8.73e-06	0.000192	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—WASF1—alcohol dependence	8.73e-06	0.000192	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—WASF1—alcohol dependence	8.68e-06	0.000191	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—WASF2—alcohol dependence	8.67e-06	0.000191	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CRHR1—alcohol dependence	8.67e-06	0.000191	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADH4—alcohol dependence	8.65e-06	0.00019	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—OPRD1—alcohol dependence	8.64e-06	0.00019	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CHRM2—alcohol dependence	8.56e-06	0.000188	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CNR1—alcohol dependence	8.53e-06	0.000188	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	8.52e-06	0.000187	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	8.51e-06	0.000187	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—AVP—alcohol dependence	8.49e-06	0.000187	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PDYN—alcohol dependence	8.46e-06	0.000186	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CNR1—alcohol dependence	8.34e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—DRD2—alcohol dependence	8.32e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR7—alcohol dependence	8.32e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—WASF1—alcohol dependence	8.31e-06	0.000183	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	8.31e-06	0.000183	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	8.31e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PDYN—alcohol dependence	8.28e-06	0.000182	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—POMC—alcohol dependence	8.24e-06	0.000181	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MAOB—alcohol dependence	8.2e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CHRM2—alcohol dependence	8.15e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—DRD2—alcohol dependence	8.14e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR7—alcohol dependence	8.14e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—DRD4—alcohol dependence	8.11e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—AVP—alcohol dependence	8.1e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—AVP—alcohol dependence	8.05e-06	0.000177	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH6—alcohol dependence	8.03e-06	0.000177	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—OPRD1—alcohol dependence	8.03e-06	0.000177	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.02e-06	0.000176	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—WASF2—alcohol dependence	7.86e-06	0.000173	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	7.86e-06	0.000173	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—OPRM1—alcohol dependence	7.86e-06	0.000173	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	7.82e-06	0.000172	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADH7—alcohol dependence	7.81e-06	0.000172	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CNR1—alcohol dependence	7.75e-06	0.00017	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—AVP—alcohol dependence	7.71e-06	0.00017	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	7.7e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—WASF2—alcohol dependence	7.7e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CRHR1—alcohol dependence	7.7e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PDYN—alcohol dependence	7.7e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR7—alcohol dependence	7.56e-06	0.000166	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—DRD2—alcohol dependence	7.56e-06	0.000166	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—AVP—alcohol dependence	7.54e-06	0.000166	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—WASF1—alcohol dependence	7.54e-06	0.000166	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GOT2—alcohol dependence	7.52e-06	0.000165	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MAOB—alcohol dependence	7.52e-06	0.000165	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GGT2—alcohol dependence	7.49e-06	0.000165	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—OPRM1—alcohol dependence	7.48e-06	0.000165	CbGpPWpGaD
Nefazodone—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.44e-06	0.000164	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR2A—alcohol dependence	7.42e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	7.39e-06	0.000163	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—WASF1—alcohol dependence	7.38e-06	0.000162	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	7.38e-06	0.000162	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	7.37e-06	0.000162	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADH7—alcohol dependence	7.36e-06	0.000162	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CHRM2—alcohol dependence	7.24e-06	0.000159	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NPY—alcohol dependence	7.23e-06	0.000159	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NPY—alcohol dependence	7.19e-06	0.000158	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CRHR1—alcohol dependence	7.15e-06	0.000157	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—WASF2—alcohol dependence	7.15e-06	0.000157	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CYP2E1—alcohol dependence	7.07e-06	0.000155	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR2A—alcohol dependence	7.06e-06	0.000155	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GGT2—alcohol dependence	7.05e-06	0.000155	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—AVP—alcohol dependence	7.01e-06	0.000154	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—AVP—alcohol dependence	6.99e-06	0.000154	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR1B—alcohol dependence	6.98e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CRH—alcohol dependence	6.98e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALDH2—alcohol dependence	6.98e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CRH—alcohol dependence	6.94e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	6.94e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NPY—alcohol dependence	6.89e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—WASF1—alcohol dependence	6.86e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—AVP—alcohol dependence	6.85e-06	0.000151	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADH1B—alcohol dependence	6.85e-06	0.000151	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	6.79e-06	0.000149	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR2A—alcohol dependence	6.74e-06	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CHRM2—alcohol dependence	6.73e-06	0.000148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	6.7e-06	0.000147	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.65e-06	0.000146	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—OPRM1—alcohol dependence	6.65e-06	0.000146	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR1B—alcohol dependence	6.64e-06	0.000146	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CRH—alcohol dependence	6.64e-06	0.000146	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	6.64e-06	0.000146	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GOT1—alcohol dependence	6.49e-06	0.000143	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GGT1—alcohol dependence	6.49e-06	0.000143	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADH1B—alcohol dependence	6.45e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR2A—alcohol dependence	6.41e-06	0.000141	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALDH2—alcohol dependence	6.39e-06	0.000141	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—AVP—alcohol dependence	6.36e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2A—alcohol dependence	6.27e-06	0.000138	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NPY—alcohol dependence	6.25e-06	0.000137	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—OPRM1—alcohol dependence	6.18e-06	0.000136	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NPY—alcohol dependence	6.12e-06	0.000135	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD4—alcohol dependence	6.1e-06	0.000134	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD4—alcohol dependence	6.07e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	6.03e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CRH—alcohol dependence	6.03e-06	0.000133	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GOT2—alcohol dependence	5.93e-06	0.00013	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—POMC—alcohol dependence	5.92e-06	0.00013	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR1B—alcohol dependence	5.9e-06	0.00013	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CRH—alcohol dependence	5.9e-06	0.00013	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	5.89e-06	0.00013	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2A—alcohol dependence	5.83e-06	0.000128	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CNR1—alcohol dependence	5.82e-06	0.000128	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MAOA—alcohol dependence	5.82e-06	0.000128	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD4—alcohol dependence	5.81e-06	0.000128	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CNR1—alcohol dependence	5.79e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2A—alcohol dependence	5.7e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NPY—alcohol dependence	5.68e-06	0.000125	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR7—alcohol dependence	5.68e-06	0.000125	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD2—alcohol dependence	5.68e-06	0.000125	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MAOB—alcohol dependence	5.67e-06	0.000125	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH4—alcohol dependence	5.66e-06	0.000124	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR7—alcohol dependence	5.65e-06	0.000124	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD2—alcohol dependence	5.65e-06	0.000124	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—POMC—alcohol dependence	5.64e-06	0.000124	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CYP2E1—alcohol dependence	5.58e-06	0.000123	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CNR1—alcohol dependence	5.55e-06	0.000122	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR1B—alcohol dependence	5.48e-06	0.000121	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CRH—alcohol dependence	5.48e-06	0.000121	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GOT2—alcohol dependence	5.44e-06	0.00012	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR7—alcohol dependence	5.41e-06	0.000119	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD2—alcohol dependence	5.41e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—POMC—alcohol dependence	5.38e-06	0.000118	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—POMC—alcohol dependence	5.35e-06	0.000118	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MAOB—alcohol dependence	5.35e-06	0.000118	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2A—alcohol dependence	5.29e-06	0.000116	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD4—alcohol dependence	5.27e-06	0.000116	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD4—alcohol dependence	5.16e-06	0.000113	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—POMC—alcohol dependence	5.12e-06	0.000113	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GOT1—alcohol dependence	5.12e-06	0.000113	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GGT1—alcohol dependence	5.12e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	5.12e-06	0.000113	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP2E1—alcohol dependence	5.11e-06	0.000112	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CNR1—alcohol dependence	5.03e-06	0.000111	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—POMC—alcohol dependence	5.01e-06	0.00011	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CNR1—alcohol dependence	4.93e-06	0.000108	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD2—alcohol dependence	4.91e-06	0.000108	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR7—alcohol dependence	4.91e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—EP300—alcohol dependence	4.89e-06	0.000107	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALDH2—alcohol dependence	4.82e-06	0.000106	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH7—alcohol dependence	4.81e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD2—alcohol dependence	4.81e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR7—alcohol dependence	4.81e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD4—alcohol dependence	4.79e-06	0.000105	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AVP—alcohol dependence	4.78e-06	0.000105	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AVP—alcohol dependence	4.76e-06	0.000105	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GGT1—alcohol dependence	4.69e-06	0.000103	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GOT1—alcohol dependence	4.69e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—POMC—alcohol dependence	4.66e-06	0.000102	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—POMC—alcohol dependence	4.65e-06	0.000102	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT2—alcohol dependence	4.61e-06	0.000101	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MAOA—alcohol dependence	4.59e-06	0.000101	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CNR1—alcohol dependence	4.58e-06	0.000101	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AVP—alcohol dependence	4.55e-06	0.0001	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—POMC—alcohol dependence	4.55e-06	0.0001	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALDH2—alcohol dependence	4.55e-06	0.0001	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD2—alcohol dependence	4.47e-06	9.82e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR7—alcohol dependence	4.47e-06	9.82e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—alcohol dependence	4.23e-06	9.3e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.22e-06	9.28e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MAOA—alcohol dependence	4.2e-06	9.25e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AVP—alcohol dependence	4.13e-06	9.09e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT2—alcohol dependence	4.1e-06	9.02e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AVP—alcohol dependence	4.05e-06	8.9e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—alcohol dependence	3.98e-06	8.75e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	3.96e-06	8.71e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT2—alcohol dependence	3.86e-06	8.5e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.86e-06	8.48e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—alcohol dependence	3.79e-06	8.33e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—alcohol dependence	3.79e-06	8.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AVP—alcohol dependence	3.76e-06	8.27e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.63e-06	7.99e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT1—alcohol dependence	3.54e-06	7.79e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GGT1—alcohol dependence	3.54e-06	7.79e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MAOB—alcohol dependence	3.5e-06	7.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—alcohol dependence	3.37e-06	7.4e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GGT1—alcohol dependence	3.34e-06	7.34e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT1—alcohol dependence	3.34e-06	7.34e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—alcohol dependence	3.18e-06	6.99e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MAOA—alcohol dependence	3.17e-06	6.98e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—alcohol dependence	3.16e-06	6.95e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—alcohol dependence	3.13e-06	6.88e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—alcohol dependence	3.03e-06	6.66e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MAOA—alcohol dependence	2.99e-06	6.58e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—alcohol dependence	2.99e-06	6.57e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.97e-06	6.54e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—alcohol dependence	2.75e-06	6.04e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—alcohol dependence	2.74e-06	6.02e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—alcohol dependence	2.69e-06	5.91e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT2—alcohol dependence	2.53e-06	5.56e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—EP300—alcohol dependence	2.51e-06	5.53e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—alcohol dependence	2.5e-06	5.49e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.38e-06	5.23e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT1—alcohol dependence	2.18e-06	4.8e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT1—alcohol dependence	2.18e-06	4.8e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EP300—alcohol dependence	2.11e-06	4.64e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EP300—alcohol dependence	2.1e-06	4.61e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—alcohol dependence	2.07e-06	4.54e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EP300—alcohol dependence	2.01e-06	4.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—EP300—alcohol dependence	1.98e-06	4.36e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MAOA—alcohol dependence	1.95e-06	4.3e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—alcohol dependence	1.95e-06	4.28e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EP300—alcohol dependence	1.82e-06	4.01e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—EP300—alcohol dependence	1.82e-06	3.99e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EP300—alcohol dependence	1.78e-06	3.92e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EP300—alcohol dependence	1.66e-06	3.64e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—EP300—alcohol dependence	1.37e-06	3.01e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—EP300—alcohol dependence	1.29e-06	2.84e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—alcohol dependence	1.27e-06	2.8e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—EP300—alcohol dependence	8.44e-07	1.86e-05	CbGpPWpGaD
